Thus, this study reveals a new regulatory mechanism for SHMT2 regulation in lung adenocarcinoma and lays a theoretical basis for targeting SHMT2 as a therapeutic target in lung adenocarcinoma. The gene discussed is SHMT2; the disease is lung adenocarcinoma.